Graft-versus-host Disease
📧 Sign up to get email alerts when something new happens for Graft-versus-host Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2009-06-18Clinical Trial Update: Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating tacrolimus and everolimus to prevent graft-versus-host disease after stem cell transplantation w…
-
CLINICAL_TRIALS withdrawal · 2009-04-29Clinical Trial Update: Anti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host Disease [Phase 1, Phase 2]
A Phase 1/2 trial evaluating an anti-CD3 and anti-CD7 ricin A immunotoxin for acute graft-versus-host disease has been withdrawn.
-
EMA withdrawal · 2008-05-23EMA Application withdrawn: orBec (beclomethasone dipropionate) — DOR BIOPHARMA UK Ltd
The EMA withdrew the application for orBec (beclomethasone dipropionate) for graft-versus-host disease.